Natural killer (NK) cells and some T cells are endowed with receptors specific for class I major histocompatibility complex (MHC) molecules that can inhibit cellular effector functions. The function of the Ly49 receptor family has been studied in vitro, but no gene transfer experiments have directly established the role of these receptors in NK cell functions. We show here that transgenic expression of the H-2Dd-specific Ly49A receptor In all NK cells and T cells conferred class I-specific Inhibition of NK cell-mediated target cell lysis as well as of T cell proliferation. Furthermore, transgene expression prevented NK cell-mediated rejection of allogeneic H-2 d bone marrow grafts by irradiated mice. These results demonstrate the function and specificity of Ly49 receptors in VlVO, and establish that their subset-specific expression is necessalt for the discrimination of MHC-dlfferent cells by NK cells in unmampulated mice.
T
wo families of NK cell receptors with specificity ~br MHC class I molecules have been described. Immunoglobulin-like killer inhibitory receptors (KIl<s) were identified on human NK cells, whereas the structurally unrelated Ly49 family of receptors, homologous to C-type lectins, were identified in the mouse (1, 2) . The Ly49 receptor family comprises eight closely related genes (Ly49A-H) on mouse chromosome 6 (2) . Expression of Ly49 receptors is largely restricted to NK cells and a small fraction of T cells (3) (4) (5) . The Ly49A, Ly49C, and Ly49G2 receptors are each expressed by 20-50% of NK cells, with some cells expressing two or even all three of the receptors (6) (7) (8) (9) (10) . Mouse NK cells expressing the Ly49A receptor are unable to kill H-2D d-and H-2Dk-expresslng tumor cell or lymphoblast target cells (3, 11) . Evidence that Ly49A binds to D d, and that anti-Ly49A antibodies allow Ly49A + NK cells to kill Dd-expressing target cells, suggested that Ly49A is a D dspecific receptor that delivers an inhibitory signal to NK cells (3, 12, 13) . NK cell subsets expressing the Ly49C or Ly49G2 receptors are inhibited by distinct MHC class I molecules, K b for the B6 allele of Ly49C and D d or L d for Ly49G2 (7, 9) .
To date, there is no evidence that genetic transfer of Ly49 receptors confers class I-specific inhibition. Therefore, the role of Ly49 receptors in regulating the various effector functions ascribed to NK cells remains unclear. This is particularly true for in vivo effector functions such as the NK cell-mediated rejection of bone marrow cells. Furthermore, the possibility has been raised that Ly49 receptors play a role as accessory receptors in class I-specific inhibinon, rather than as the primary determinants of specificity 2037 (14) . These concerns are enhanced by the failure to date to isolate munne homologues of the human KIP. family of class I-specific inhibitory receptors. It remains possible that the two receptor families coexist in mice and mediate distinct functions. To address directly the role of Ly49A in class 1-specific inhibition of NK and T cell functions, we have generated transgenic mice in which the Ly49A cDNA is expressed by all NK cells and T cells. Transgenic expression of Ly49A in all NK cells from H-2 b mice prevented these mice from rejecting an H-2 d bone marrow allograft, and resulted in impaired in vitro cytolysis of tumor target cells expressing the D d Ly49A ligand. Furthermore, expression of Ly49A in T cells specifically inhibited their capacity to mount a proliferative response to stimulator cells that express class I llgands of Ly49A.
Materials and Methods
Generation of Ly49A Transgenic Mice. A Ly49A cDNA clone was isolated from the C57BL/6 (B6)-derived thymoma EL-4 using reverse transcriptase and the polymerase chain reaction (1KT-PC1K) with Ly49A-specific primers containing an EcoRI site (8) . Compared with the published Ly49A sequence (2), our cDNA contained two silent base pair changes, and one change that resulted in a subsntutxon at position 106 of Met to Ile. This armno acid substitution, however, was also found in Ly49A cDNAs we isolated from B6 A-LAK cells. The Ly49A cDNA clone was subcloned into the class I promoter expression cassette (15) and injected into fertdized (B6 × CBA/J)F 2 eggs. Transgenlc founder mice were idennfied by Southern blotting with an Ly49A cDNA probe and by staining penpheral blood lymphocytes with FITClabeled anti-Ly49A mAbs A1 or JR9-318. B6 backcross mice were typed for H-2 expression with antibodies specific for H-2D b (28-14-8s) or H-2K k (15-5-5, PharMmgen, San Diego, CA). The allotype of the NK complex on chromosome 6 was monitored with the B6 allele-specific mAb PK136 (anti-NKl.1). The mice used had been backcrossed two or three times to B6 mice, were homozygous H-2 b/b, and were homozygous for the B6 NK gene complex. Bone Marrow Graft Rejection. Recipient B10.D2 and 8-to 12-week-old Ly49A transgenac mice or control littermates, backcrossed three times to B6 mace, were irradiated (950 rads from a 137Cs source) and inoculated intravenously with 5 × 106 bone marrow cells from B6 or B10.D2 mice, or from [32m / B6. Recipient mice were injected lntraperltoneally five days later with 3 I.LC1 of 12SI-labeled 5-iodo-2' deoxyuridine (12sI-UdR). Isotope incorporation in the recipient spleens was determined 24 h later, after rinsing the spleens with PBS. For NK cell depletion, recipient mice were injected intraperitoneally 24 h prior to lrradmtion and bone marrow transfer with either 200 b~g of mAb PK136 (antl-NKl.1, mouse IgG2a) or the isotype matched control mAb 14-4-4 (anti-MHC class II E k, mouse IgG2a).
Results and Discussion
A mouse Ly49A c D N A clone was isolated from the C57BL/6 036) thymoma EL-4 and inserted into the class I promoter/immunoglobulin enhancer expression cassette (15) to generate transgenic mice. A transgenic 036 × CBA/J)F 2 founder, with a high (>15) transgene copy number, was back-crossed three times to B6 (H-2 b) mice to establish a transgenic line (fine No. 2). The transgenic mice and nontransgenic littermates contained a comparable frequency (Fig. 1 A) and number (1.0 + 0.4 × 106, n = 6 vs. 0,9 + 0.3 × 10 6, n = 4, respectively) of N K cells, indicating that transgene expression did n o t prevent N K cell development. Approximately 20% of N K cells in nontransgenic littermates expressed Ly49A (Fig. 1 A) , similar to the proportion in B6 mice (3) . In contrast, virtually all N K cells (>98.0%) in transgenic mice expressed Ly49A on the cell surface (Fig. 1 A) . Importantly, the cell surface expression levels of Ly49A on N K cells derived from transgenic mice and n o ntransgenic littermates were not significantly different, as determined by staining with the anti-Ly49A mAbs J R 9 -3 1 8 (mean fluorescence intensity (MFI) 94 + 12 vs. 105 + 7, respectively) or A1 (data not shown).
T h e Ly49A transgene was expressed not only by N K cells, but also on the surface of C D 4 + and C D 8 + T cells ( Fig. 1 /3 ). T h e peripheral (Fig. 1 B) and thymic (data n o t shown) T cell compartments appeared normal, suggesting that the transgene did n o t alter T cell development in H -2 b ,nice. Furthermore, transgene expression was detected on T C R y 8 + and NK1.1 + T cells (data not shown) and at variable levels on B cells (Fig. 1 B) . Transgenic macrophages expressed little or no Ly49A on the cell surface (data not shown). These results extend a prev,ous report that n o n -N K I . 1 + cells can support cell surface expression of Ly49 receptors (6, 13) .
The specificity and function of the Ly49A transgene in N K cells was estabhshed by its ability to confer H -2 D a-
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Lit t e._rmat e LV49A.Tq (Fig. 2) . Similar results were obtained with freshly isolated, poly I/C-activated NK cell preparations (data not shown). These results represent direct evidence that Ly49 molecules are sufficient to confer class I-specific inhibition of target cell lysis to NK cells. A previous study employing viral-mediated gene transduction reached a similar conclusion with respect to the structurally unrelated human KIlL gene family (17) . Previous studies have demonstrated that NK cells me&ate the rejection by irradiated mice of allogeneic or class I-deficient bone marrow cells, and of parental-type marrow grafts by F 1 hybrids of H-2 disparate mouse stratus (18) . To establish the role of Ly49 receptors in NK cell specificity and function in vivo, we determined the effects of Ly49A transgene expression on the capacity of irradiated H-2 b mice to reject an allogeneic H-2 d bone marrow graft, a reaction that is mediated by NK cells (19) . Marrow engraftment was monitored by the incorporation of 5-[12sI]iodo -2'-deoxyuridine in spleen cells, indicating donor cell proliferation (18) . Whereas nontransgenic H-2 b mice rejected the allogeneic H-2 a (B10.D2) bone marrow grafts, Ly49A-transgenic H-2 b mice completely accepted these grafts, as demonstrated by the high level of isotope incorporation in their spleens (Fig. 3 A) . As expected, both Ly49A transgemc and nontransgenic mice accepted H-2-identical B6 Ly49A transgemc H-2 b mice are unable to reject an H-2 a bone marrow allograft. (A) P, ejectlon of bone marrow grafts by irradiated mice was assayed with the splemc ~2sI-UdR Incorporation assay, ,n which low levels of ISOtope incorporation reflect rejection of the graft, and high levels of incorporation reflect graft acceptance. Each symbol represents an Individual recipient animal Four recipient mace were used per expenmental group in most cases. The transgenlc mace, like the control mace, accepted H-2-1dentical (H-2 b) grafts. In contrast with nontransgenlc littermates, Ly49A-transgemc H-2 b mice were unable to reject H-2 a bone marrow grafts This was not due to a general inability to reject bone marrow cells, since grafts derived from [32m-deficient mice were readily relected (B) Bone marrow graft rejection in Ly49A transgemc mice is me&ated by NK1 1 + cells since depletmn of NK1 1 + cells results m the inablhty to reject grafts derived from {32m-deficient mice.
(H-2 b) bone marrow grafts.The Ly49A-transgenic mice retained the capacity to reject bone marrow grafts from class I-deficient (i.e., [32m-) mice (20) (Fig. 3 A) , a reacnon that was prevented by pretreating the mice with anti-NKI.1 antibody, but not with irrelevant (anti-MHC class II I-E) antibody (Fig. 3 B) . Hence, the transgene specifically prevented rejection of H-2 d bone marrow grafts, and did not affect NK-mediated rejection of 132m-bone marrow grafts. This experiment demonstrates that the capacity to reject H-2 d grafts is prevented when Ly49A is expressed on all NK ceils, as opposed to on a subset of NK cells as observed in normal mice. Therefore, a significant conclusion of our results is that the alloreactivity observed in the NK cell compartment is due to the failure of many NK cells to express a given class I-specific inhibitory receptor, i.e., to the fact that Ly49 receptor expression is normally restricted to NK cell subsets.
The demonstration that the Ly49A transgene prevents rejection of H-2 d bone marrow cell grafts provides direct evidence of a role for Ly49 receptors in vivo. A role for Ly49 receptors in bone marrow cell rejection was previously inferred from in vitro cytolysis experiments that mirror the specificity of bone marrow cell rejecnon (9) . Some caution is warranted in equating the cytolysis experiments with bone marrow cell rejection; however, when it is considered that marrow rejection remains largely intact in mice that lack perforin-or Fas-mediated cytotoxic function (21) . Furthermore, the possibility that MHC recognition by NK cells can in some cases induce, rather than inhibit bone marrow rejection is not reflected by the in vitro assays (22, 23) . A role for Ly49 receptors in bone marrow cell rejection was also previously suggested by correlative evidence that Ly49C ÷ NK cells are essential for rejection of H-2 d bone marrow grafts by H-2 b mice (24) . Since cells expressing Ly49C are present in normal numbers in Ly49A transgenic mice (data not shown), a hkely explanation of our results is that Ly49A transgene expression confers Dd-specific inhibition to all Ly49C ÷ NK cells, thus preventing these cells from rejecting the H-2 d bone marrow cell allograft. To address whether Ly49 receptors can confer class I-specific inhibition to lymphocytes other than NK cells, we addressed the effects of Ly49A transgene expression on the proliferative response of conventional CD4 ÷ T cells, most of which are normally Ly49A- (Fig. 1 B) , to allogenelc class II molecules. CD4 + T cell-enriched responder cells from transgenic and nontransgenic mice responded equivalently to stimulation with [32m-deficient B10.B1K spleen cells (Fig. 4) . These stimulator cells present the allogeneic A k and E k class II molecules, but do not express class I molecules. Stimulator cells from class I + B10.BR mice, which also express A k and E k but express in addition the Ly49A-specific D k class I molecule (11) , ehcited a good response from nontransgenic CD4 + T cells, but the response of the Ly49A-transgenic CD4 + T cells was completely inhibited. Thus, the Ly49A-class I interaction can even inhibit T cell receptor-mediated responses to allogeneic class II molecules. Similar results were obtained when we tested the CD8 + T cell proliferative response to allogenelc MHC molecules (data not shown).
The finding that Ly49A functions in T cells indicates that no additional NK cell-specific molecules are required for Ly49 receptor activity, and suggests that the relevant inhibitory signaling pathways are conserved in NK and T cells and perhaps all lymphoid cells. In line with this observation, previous studies in the human system demonstrated KIR-mediated, class I-specific inhibition of cytolysis by certain T cell clones (25) . The recent implication of the tyrosine phosphatases PTPlC and/or PTPlD in the downmodulation or prevention of immune responses by B cells, T cells, and NK cells lends further support for this notion (26) (27) (28) . With regard to Ly49A, the retention of the signaling pathway in T cells is of particular interest because a small fraction oft cells express Ly49 receptors on their surface (4, 5) . Therefore, besides regulating NK cell function, Ly49A-class I interactions may be important in normal mice for the regulation of some T cells (25) .
In conclusion, we have demonstrated that the Ly49A molecule is the only NK cell-specific receptor required to confer inhibitory class I specificity to NK cells and T cells, and most significantly, that these receptors regulate NK cell function in vivo. The results suggest that Ly49 receptors regulate multiple cellular effector functions, and do not represent accessory receptors for class I recognition. Furthermore, the data indicate that the expression of Ly49 receptors by NK cell subsets in normal mice is essential for the discrimination of class I-different cells. This property is probably necessary to allow NK cells to attack variant cells in which the expression of some but not all host class I molecules are repressed due to infection, mutation, or transformation (29) .
